Bio-Techne
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
BAUMGARTNER ROBERT V director
Stock Option (right to buy) 2,613 N/A N/A
Option
BAUMGARTNER ROBERT V director
Stock Option (right to buy) 3,854 N/A N/A
Option
BAUMGARTNER ROBERT V director
Common Stock 3,854 N/A N/A
Sale
BAUMGARTNER ROBERT V director
Common Stock 3,854 N/A N/A
Option
BAUMGARTNER ROBERT V director
Stock Option (right to buy) 3,533 N/A N/A
Sale
BAUMGARTNER ROBERT V director
Common Stock 3,533 N/A N/A
Option
BAUMGARTNER ROBERT V director
Common Stock 3,533 N/A N/A
Sale
LUCAS ROGER C director
Common Stock 100 N/A N/A
Sale
LUCAS ROGER C director
Common Stock 100 N/A N/A
Sale
LUCAS ROGER C director
Common Stock 100 N/A N/A
Sale
LUCAS ROGER C director
Common Stock 100 N/A N/A
Sale
DINARELLO CHARLES A director
Common Stock 5,000 N/A N/A
Sale
LUCAS ROGER C director
Common Stock 500 N/A N/A
Option
DINARELLO CHARLES A director
Stock Options (Right to Buy) 5,000 N/A N/A
Option
DINARELLO CHARLES A director
Common Stock 5,000 N/A N/A
Sale
LUCAS ROGER C director
Common Stock 100 N/A N/A
Option
HIPPEL JAMES officer: Chief Financial Officer
Restricted Stock Units 1,666 N/A N/A
Option
HIPPEL JAMES officer: Chief Financial Officer
Common Stock 1,666 N/A N/A
Sale
LUCAS ROGER C director
Common Stock 100 N/A N/A
Option
LUCAS ROGER C director
Common Stock 5,000 N/A N/A
Option
LUCAS ROGER C director
Stock Options (Right to Buy) 5,000 N/A N/A
Sale
LUCAS ROGER C director
Common Stock 5,000 N/A N/A
Sale
LUCAS ROGER C director
Common Stock 5,000 N/A N/A
Option
LUCAS ROGER C director
Common Stock 5,000 N/A N/A
Option
LUCAS ROGER C director
Stock Option (right to buy) 5,000 N/A N/A
Sale
LUCAS ROGER C director
Common Stock 5,000 N/A N/A
Option
LUCAS ROGER C director
Common Stock 5,000 N/A N/A
Option
LUCAS ROGER C director
Stock Option (right to buy) 5,000 N/A N/A
Option
EANSOR NORMAN DAVID officer: President-Protein Scie..
Restricted Stock Units 1,667 N/A N/A
Option
EANSOR NORMAN DAVID officer: President-Protein Scie..
Common Stock 1,667 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Common Stock 385 N/A N/A
Sale
STEER RANDOLPH C director
Common Stock 1,000 N/A N/A
Option
VERONNEAU MARCEL officer: SVP - Clinical Controls
Stock Option 385 N/A N/A
Option
HIPPEL JAMES officer: Chief Financial Officer
Restricted Stock Units 1,666 N/A N/A
Option
HIPPEL JAMES officer: Chief Financial Officer
Common Stock 1,666 N/A N/A
Sale
OCONNELL HOWARD V director
Common Stock 5,000 N/A N/A
Option
OCONNELL HOWARD V director
Common Stock 5,000 N/A N/A
Option
OCONNELL HOWARD V director
Stock Option (right to buy) 5,000 N/A N/A
Option
DINARELLO CHARLES A director
Stock Option 1,500 N/A N/A
Option
DINARELLO CHARLES A director
Common Stock 1,500 N/A N/A
Sale
HOLBROOK KAREN A director
Common Stock 1,000 N/A N/A
Sale
REAGAN KEVIN J officer: Senior VP - Biotech
Common Stock 2,591 N/A N/A
Option
REAGAN KEVIN J officer: Senior VP - Biotech
Common Stock 2,591 N/A N/A
Option
REAGAN KEVIN J officer: Senior VP - Biotech
Stock Option 2,591 N/A N/A
Sale
DINARELLO CHARLES A director
Common Stock 3,000 N/A N/A
Sale
REAGAN KEVIN J officer: Senior VP - Biotech
Common Stock 1,000 N/A N/A
Option
REAGAN KEVIN J officer: Senior VP - Biotech
Stock Option 1,000 N/A N/A
Option
REAGAN KEVIN J officer: Senior VP - Biotech
Common Stock 1,000 N/A N/A
Option
DINARELLO CHARLES A director
Stock Options 5,000 N/A N/A
Option
DINARELLO CHARLES A director
Common Stock 5,000 N/A N/A

Showing 400 to 450 of 649 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.